396 related articles for article (PubMed ID: 27509450)
1. Evaluation of 126 Consecutive Stereotactic Procedures: Brain Biopsy, Diagnostic Yield, Accuracy, Non-Diagnostic Results, Complications and Follow-up.
Hakan T; Aker FV
Turk Neurosurg; 2016; 26(6):890-899. PubMed ID: 27509450
[TBL] [Abstract][Full Text] [Related]
2. Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging.
Bernays RL; Kollias SS; Khan N; Brandner S; Meier S; Yonekawa Y
J Neurosurg; 2002 Aug; 97(2):354-62. PubMed ID: 12186464
[TBL] [Abstract][Full Text] [Related]
3. The safety and diagnostic value of frame-based and CT-guided stereotactic brain biopsy technique.
Ersahin M; Karaaslan N; Gurbuz MS; Hakan T; Berkman MZ; Ekinci O; Denizli N; Aker FV
Turk Neurosurg; 2011; 21(4):582-90. PubMed ID: 22194120
[TBL] [Abstract][Full Text] [Related]
4. Frame-based stereotactic biopsies using an intraoperative MR-scanner are as safe and effective as conventional stereotactic procedures.
Neumann JO; Campos B; Younes B; Jakobs M; Jungk C; Beynon C; Deimling AV; Unterberg A; Kiening K
PLoS One; 2018; 13(10):e0205772. PubMed ID: 30352066
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment.
Kim JE; Kim DG; Paek SH; Jung HW
Acta Neurochir (Wien); 2003 Jul; 145(7):547-54; discussion 554-5. PubMed ID: 12910397
[TBL] [Abstract][Full Text] [Related]
6. [Complications and diagnostic yield of stereotactic biopsy for the patients with malignant brain tumors].
Takahashi H; Sugai T; Uzuka T; Kano M; Honma J; Grinev I; Tanaka R
No Shinkei Geka; 2004 Feb; 32(2):135-40. PubMed ID: 15031974
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic biopsy of intracranial brain lesions. High diagnostic yield without increased complications: 65 consecutive biopsies with early postoperative CT scans.
Fritsch MJ; Leber MJ; Gossett L; Lulu BA; Hamilton AJ
Stereotact Funct Neurosurg; 1998; 71(1):36-42. PubMed ID: 10072672
[TBL] [Abstract][Full Text] [Related]
8. Computerized Tomography-Guided Stereotactic Biopsy of Intracranial Lesions: Report of 500 Consecutive Cases.
Can SM; Turkmenoglu ON; Tanik C; Uysal E; Ozoner B; Kaldirimoglu SA; Musluman AM; Yilmaz A; Cavusoglu H; Bayindir C; Aydin Y
Turk Neurosurg; 2017; 27(3):395-400. PubMed ID: 27593799
[TBL] [Abstract][Full Text] [Related]
9. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies.
Grossman R; Sadetzki S; Spiegelmann R; Ram Z
Acta Neurochir (Wien); 2005 Jun; 147(6):627-31; discussion 631. PubMed ID: 15821863
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of diagnostic accuracy of different brain biopsy procedures.
Jain D; Sharma MC; Sarkar C; Gupta D; Singh M; Mahapatra AK
Neurol India; 2006 Dec; 54(4):394-8. PubMed ID: 17114850
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopy-supported frame-based image-guided stereotactic biopsy of parenchymal brain lesions: comparative evaluation of diagnostic yield and diagnostic accuracy.
Chernov MF; Muragaki Y; Ochiai T; Taira T; Ono Y; Usukura M; Maruyama T; Nakaya K; Nakamura R; Iseki H; Kubo O; Hori T; Takakura K
Clin Neurol Neurosurg; 2009 Jul; 111(6):527-35. PubMed ID: 19427112
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic biopsy of brainstem lesions: 21 years experiences of a single center.
Quick-Weller J; Lescher S; Bruder M; Dinc N; Behmanesh B; Seifert V; Weise L; Marquardt G
J Neurooncol; 2016 Sep; 129(2):243-50. PubMed ID: 27291894
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic biopsy in the era of advanced neuroimaging. Does the minimal therapeutic gain justify its current wide use?
Stranjalis G; Protopapa D; Sakas DE; Chondros D
Minim Invasive Neurosurg; 2003 Apr; 46(2):90-3. PubMed ID: 12761679
[TBL] [Abstract][Full Text] [Related]
14. Complications of MRI-guided stereotactic biopsy of brain lymphoma.
Malikova H; Liscak R; Latnerova I; Guseynova K; Syrucek M; Pytlik R
Neuro Endocrinol Lett; 2014; 35(7):613-8. PubMed ID: 25617885
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of stereotactic biopsy for intracranial lesions.
Hall WA
Cancer; 1998 May; 82(9):1749-55. PubMed ID: 9576298
[TBL] [Abstract][Full Text] [Related]
16. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesion.
Jain D; Sharma MC; Sarkar C; Deb P; Gupta D; Mahapatra AK
Brain Tumor Pathol; 2006 Oct; 23(2):71-5. PubMed ID: 18095122
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic computed tomography-guided brain biopsy: diagnostic yield based on a series of 170 patients.
Ferreira MP; Ferreira NP; Pereira Filho Ade A; Pereira Filho Gde A; Franciscatto AC
Surg Neurol; 2006; 65 Suppl 1():S1:27-1:32. PubMed ID: 16427444
[TBL] [Abstract][Full Text] [Related]
18. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy.
Kulkarni AV; Guha A; Lozano A; Bernstein M
J Neurosurg; 1998 Jul; 89(1):31-5. PubMed ID: 9647169
[TBL] [Abstract][Full Text] [Related]
19. Frameless stereotaxy with scalp-applied fiducial markers for brain biopsy procedures: experience in 218 cases.
Barnett GH; Miller DW; Weisenberger J
J Neurosurg; 1999 Oct; 91(4):569-76. PubMed ID: 10507376
[TBL] [Abstract][Full Text] [Related]
20. Postoperative management of patients after stereotactic biopsy: results of a survey of the AANS/CNS section on tumors and a single institution study.
Warnick RE; Longmore LM; Paul CA; Bode LA
J Neurooncol; 2003 May; 62(3):289-96. PubMed ID: 12777081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
